Tonix Pharmaceuticals Holding Corp. (TNXP) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Tonix Pharmaceuticals Hol...

    NASDAQ: TNXP · Real-Time Price · USD
    24.00
    -0.70 (-2.83%)
    At close: Sep 25, 2025, 3:59 PM
    24.03
    0.12%
    After-hours: Sep 25, 2025, 07:46 PM EDT

    Tonix Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 10.09M 7.77M 9.03M n/a
    Cost of Revenue
    		 7.76M 4.74M 1M 62.86M
    Gross Profit
    		 2.33M 3.03M 8.03M -62.86M
    Operating Income
    		 -136.7M -118.38M -112.05M -92.39M
    Interest Income
    		 n/a n/a 1.87M 106K
    Pretax Income
    		 -130.04M -116.66M -110.22M -92.29M
    Net Income
    		 -130.04M -116.66M -116.88M -92.29M
    Selling & General & Admin
    		 40.1M 34.75M 30.21M 23.55M
    Research & Development
    		 39.97M 86.66M 81.88M 68.84M
    Other Expenses
    		 58.96M n/a n/a 29.48M
    Operating Expenses
    		 139.03M 121.41M 112.09M 92.39M
    Interest Expense
    		 n/a n/a 215K n/a
    Selling & Marketing Expenses
    		 36.7M n/a n/a n/a
    Cost & Expenses
    		 87.84M 126.15M 112.09M 92.39M
    Income Tax Expense
    		 n/a n/a 5.4M n/a
    Shares Outstanding (Basic)
    		 2.26M 1.83M 3.07M 7.05M
    Shares Outstanding (Diluted)
    		 2.26M 1.83M 3.07M 7.05M
    EPS (Basic)
    		 -176.6 -6.37K -811.68 -1.67K
    EPS (Diluted)
    		 -176.6 -6.37K -811.68 -1.67K
    EBITDA
    		 -126.61M -114.09M -110.84M -92.26M
    EBIT
    		 -130.04M -118.38M -112.09M -92.31M
    Depreciation & Amortization
    		 3.42M 4.29M 1.25M 50K

    Add to Watchlist